Lipopolysaccharide Binding Protein (LBP) Peptide
LBP
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN940529
Quick Overview for Lipopolysaccharide Binding Protein (LBP) Peptide (ABIN940529)
Target
LBP
(Lipopolysaccharide Binding Protein (LBP))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- LLGSESSGRP TVTASSCSSD IADVEVDMSG DLGWLLNLFH NQIESKFQKV
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of LBP antibody,
Alternative Names: LBP control peptide, LBP antibody Blocking Peptide, Anti-LBP Blocking Peptide, Lipopolysaccharide Binding Protein Blocking Peptide, MGC22233 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- LBP (Lipopolysaccharide Binding Protein (LBP))
-
Background
- LBP is involved in the acute-phase immunologic response to gram-negative bacterial infections. Gram-negative bacteria contain a glycolipid, lipopolysaccharide (LPS), on their outer cell wall. Together with bactericidal permeability-increasing protein (BPI), the protein binds LPS and interacts with the CD14 receptor, probably playing a role in regulating LPS-dependent monocyte responses.
-
Molecular Weight
- 51 kDa
Target
-
You are here:
